Most pharmacists believe in medical cannabis and are seeking formal training for correct administration, yet prohibitionists prefer to wedge a bureaucrat between you and your doctor. According to several studies, even the medical community thinks that's stupid.
A 2019 survey of the California Pharmacists Association found that “a majority of providers believe that marijuana has medical efficacy… yet most providers report that they neither have much information about medical marijuana nor do they know where to get such information.” Likewise, 58 percent of pharmacy students in a 2015 survey support the national legalization of medical cannabis, while another study found that nearly 90 percent of prescribing healthcare professionals want more formal cannabis training. Even across the pond in England, where prohibition is much more stringent, nearly 90 percent of Royal Pharmaceutical Society members think cannabis should be rescheduled for increased medical access and the majority support legalization.
Similar support can be found in other fields. For example, the Journal of Drugs in Dermatology published a survey last December in which 86 percent of dermatologists thought cannabinoids should be legal for medical treatment, and 94 percent supported research into the dermatologic uses of cannabinoids.
Researchers with the Department of Veterans Affairs, of all places, explained why pharmacists face so many hurdles in terms of information, guidelines, access and prescribing rights in a study titled “Navigating Blind in the Green Rush.” They wrote, “Research on cannabis is difficult to conduct as it is classified as a Schedule I drug with high potential for abuse and currently no accepted medical use in treatment. As a result, no standard dosing procedures exist and the lack of conclusive scientific evidence has left clinical providers without evidence-based guidelines about if, when, and how to guide clients on using cannabis safely.”
The VA researchers also offered a recommendation for policy change: “The removal of regulatory barriers would enable researchers to address key public health questions about the potential therapeutic and adverse effects of cannabis use. Additionally, funds for research, clinician education, and public health education initiatives are necessary to reduce risk around cannabis use in the United States.”
Prohibitionists, your dumbass days are numbered.